Biotech partnership

By Mike Lee -- Bee Staff Writer

Published Wednesday, October 29, 2003

Vacaville-based biotechnology company Large Scale Biology Corp. on Tuesday announced a collaboration with Schering-Plough Animal Health Corp. to produce and evaluate several vaccines for treating viral infections in animals.

If initial research is successful, the agreement opens the door for Large Scale Biology to manufacture and supply vaccine products for clinical trials and possible commercialization by Schering-Plough Animal Health, based in Union, N.J.

A joint press release said financial terms were not disclosed.

Large Scale produces pharmaceutical compounds in nonfood plants, such as tobacco, a process called biomanufacturing.

The company, founded in 1987, trades on the Nasdaq as LSBC. Its shares closed Tuesday at $1.61, up 31 cents.